{"transactions":[{"id":710611,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-13T21:00:07.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":false,"shares":31249,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":68751,"derivative":{"exercise_price":21.77,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":31249},"source":{"system":"sec-edgar","filing":"0001992324-26-000008","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000008/ownership.xml","form_type":"4"}},{"id":710610,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-07-13T21:00:07.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":5566,"price":101.97,"value":567565.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $101.95 to $102.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001992324-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000008/ownership.xml","form_type":"4"}},{"id":710609,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-07-13T21:00:07.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":15329,"price":101.24,"value":1551907.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.78 to $101.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":5566,"source":{"system":"sec-edgar","filing":"0001992324-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000008/ownership.xml","form_type":"4"}},{"id":710608,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-07-13T21:00:07.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":10354,"price":100.22,"value":1037677.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.75 to $100.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":20895,"source":{"system":"sec-edgar","filing":"0001992324-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000008/ownership.xml","form_type":"4"}},{"id":710607,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-07-13T21:00:07.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":true,"shares":31249,"price":21.77,"value":680290.73,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."}],"balance_after":31249,"source":{"system":"sec-edgar","filing":"0001992324-26-000008","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000008/ownership.xml","form_type":"4"}},{"id":810393,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-10T20:52:24.000Z","date":"2026-04-09","kind":"exercise","planned":true,"acquired":false,"shares":8224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":71776,"derivative":{"exercise_price":17.88,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":8224},"source":{"system":"sec-edgar","filing":"0001992324-26-000006","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000006/ownership.xml","form_type":"4"}},{"id":810392,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-10T20:52:24.000Z","date":"2026-04-09","kind":"sale","planned":true,"acquired":false,"shares":8224,"price":89.84,"value":738844.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $89.75 to $89.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001992324-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000006/ownership.xml","form_type":"4"}},{"id":810391,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-10T20:52:24.000Z","date":"2026-04-09","kind":"exercise","planned":true,"acquired":true,"shares":8224,"price":17.88,"value":147045.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."}],"balance_after":8224,"source":{"system":"sec-edgar","filing":"0001992324-26-000006","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000006/ownership.xml","form_type":"4"}},{"id":822882,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The shares of common stock underlying this stock option award vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":17.88,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822881,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":false,"shares":74367,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The shares of common stock underlying this stock option award vested as to 25% of the shares on June 2, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":10399,"derivative":{"exercise_price":8.44,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":74367},"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822880,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":7232,"price":85.54,"value":618625.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $85.25 to $85.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822879,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":19469,"price":84.57,"value":1646493.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $84.25 to $85.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":7232,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822878,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":59800,"price":83.9,"value":5017220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $83.25 to $84.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":26701,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822877,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":2366,"price":82.84,"value":195999.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $82.25 to $83.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":86501,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822876,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":800,"price":81.36,"value":65088.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $81.15 to $81.52, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":88867,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822875,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":1485,"price":80.25,"value":119171.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $80.11 to $81.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":89667,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822874,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":21825,"price":78.86,"value":1721119.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $78.74 to $79.66, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":91152,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822873,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"sale","planned":true,"acquired":false,"shares":1390,"price":78.33,"value":108878.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $77.74 to $78.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":112977,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822872,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":40000,"price":17.88,"value":715200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."}],"balance_after":114367,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":822871,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Common Stock","published_at":"2026-04-01T21:26:57.000Z","date":"2026-03-31","kind":"exercise","planned":true,"acquired":true,"shares":74367,"price":8.44,"value":627657.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2025."}],"balance_after":74367,"source":{"system":"sec-edgar","filing":"0001992324-26-000004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000004/ownership.xml","form_type":"4"}},{"id":919419,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-04T22:40:04.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2026, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":52.46,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001992324-26-000002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232426000002/ownership.xml","form_type":"4"}},{"id":979038,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-06T01:00:04.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of common stock underlying this stock option award vested as to 25% of the shares on June 2, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":84766,"derivative":{"exercise_price":8.44,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001992324-25-000005","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232425000005/ownership.xml","form_type":"4"}},{"id":979037,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2025-12-06T01:00:04.000Z","date":"2025-12-04","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":45.18,"value":903600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported above is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001992324-25-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232425000005/ownership.xml","form_type":"4"}},{"id":979036,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2025-12-06T01:00:04.000Z","date":"2025-12-04","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":8.44,"value":168800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001992324-25-000005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232425000005/ownership.xml","form_type":"4"}},{"id":1032329,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-26T00:02:32.000Z","date":"2025-09-23","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after September 23, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":37.87,"expiration_date":"2035-09-23","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001992324-25-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000199232425000003/ownership.xml","form_type":"4"}},{"id":1042868,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-11T21:20:43.000Z","date":"2025-09-09","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock underlying this stock option award vested as to 25% of the shares on June 2, 2023, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":104766,"derivative":{"exercise_price":8.44,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-25-114293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017025114293/ownership.xml","form_type":"4"}},{"id":1042867,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2025-09-11T21:20:43.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":35,"value":700000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-114293","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017025114293/ownership.xml","form_type":"4"}},{"id":1042866,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Common Stock","published_at":"2025-09-11T21:20:43.000Z","date":"2025-09-09","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":8.44,"value":168800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2025."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950170-25-114293","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017025114293/ownership.xml","form_type":"4"}},{"id":1284869,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T21:18:46.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":22.07,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000950170-25-013471","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017025013471/ownership.xml","form_type":"4"}},{"id":1500440,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO & CBO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-29T00:04:33.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after May 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":21.77,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-065564","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024065564/ownership.xml","form_type":"4"}},{"id":1669540,"issuer":{"id":1813,"kind":"organization","name":"Dianthus Therapeutics, Inc. /DE/","symbol":"DNTH"},"owners":[{"id":30813,"kind":"person","name":"Savitz Ryan","position":1,"cik":"0001992324","reported_name":"Savitz Ryan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T21:41:24.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying this stock option award will vest in equal monthly installments over the four years after January 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":17.88,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000950170-24-007986","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1690585/000095017024007986/ownership.xml","form_type":"4"}}]}